EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differences in Bone Metabolism between Children with Prader–Willi Syndrome during Growth Hormone Treatment and Healthy Subjects: A Pilot Study

Joanna Gajewska iD, Magdalena Chełchowska iD, Katarzyna Szamotulska, Witold Klemarczyk iD, Małgorzata Strucińska, Jadwiga Ambroszkiewicz iD

International Journal of Molecular Sciences · 23.08.2024 · 25 (17) · 9159

DOI: 10.3390/ijms25179159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.08.2024. Verfasst von Joanna Gajewska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Bone and Bones, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite therapy with growth hormone (GH) in children with Prader–Willi syndrome (PWS), low bone mineral density and various orthopedic deformities have been observed often. Therefore, this study aimed to analyze bone markers, with an emphasis on vitamin K-dependent proteins (VKDPs), in normal-weight children with PWS undergoing GH therapy and a low-energy dietary intervention. Twenty-four children with PWS and 30 healthy children of the same age were included. Serum concentrations of bone alkaline phosphatase (BALP), osteocalcin (OC), carboxylated-OC (Gla-OC), undercarboxylated-OC (Glu-OC), periostin, osteopontin, osteoprotegerin (OPG), sclerostin, C-terminal telopeptide of type I collagen (CTX-I), and insulin-like growth factor-I (IGF-I) were determined using immunoenzymatic methods. OC levels and the OC/CTX-I ratios were lower in children with PWS than in healthy children (p = 0.011, p = 0.006, respectively). Glu-OC concentrations were lower (p = 0.002), but Gla-OC and periostin concentrations were higher in patients with PWS compared with the controls (p = 0.005, p < 0.001, respectively). The relationships between IGF-I and OC (p = 0.013), Gla-OC (p = 0.042), and the OC/CTX-I ratio (p = 0.017) were significant after adjusting for age in children with PWS. Bone turnover disorders in children with PWS may result from impaired bone formation due to the lower concentrations of OC and the OC/CTX-I ratio. The altered profile of OC forms with elevated periostin concentrations may indicate more intensive carboxylation processes of VKDPs in these patients. The detailed relationships between the GH/IGF-I axis and bone metabolism markers, particularly VKDPs, in children with PWS requires further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prader-Willi SyndromeBone and BonesBiomarkersHumansChildMaleFemalePilot ProjectsHuman Growth HormoneChild, PreschoolOsteocalcinAdolescentInsulin-Like Growth Factor IBone DensityAlkaline PhosphataseCase-Control Studies

Stichwörter der Autor:innen

Gla-osteocalcinGlu-osteocalcinPrader–Willi syndromeinsulin-like growth factor-Iperiostintotal-IGF-binding protein-3

Substanzen

BiomarkersHuman Growth HormoneOsteocalcinInsulin-Like Growth Factor IAlkaline Phosphatase

Autor:innen und Institutionen

  • Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
  • Department of Epidemiology and Biostatistics, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
  • Department of Nutrition, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.

ORCID-Profile: Joanna Gajewska, Magdalena Chełchowska, Witold Klemarczyk, Jadwiga Ambroszkiewicz

Zitieren

APA

Gajewska, J., Chełchowska, M., Szamotulska, K., Klemarczyk, W., Strucińska, M., & Ambroszkiewicz, J. (2024). Differences in Bone Metabolism between Children with Prader–Willi Syndrome during Growth Hormone Treatment and Healthy Subjects: A Pilot Study. International Journal of Molecular Sciences, 25(17), 9159. https://doi.org/10.3390/ijms25179159

Vancouver

Gajewska J, Chełchowska M, Szamotulska K, Klemarczyk W, Strucińska M, Ambroszkiewicz J. Differences in Bone Metabolism between Children with Prader–Willi Syndrome during Growth Hormone Treatment and Healthy Subjects: A Pilot Study. International Journal of Molecular Sciences. 2024;25(17):9159. doi:10.3390/ijms25179159

BibTeX
@article{Gajewska2024,
  author = {Gajewska, Joanna and Chełchowska, Magdalena and Szamotulska, Katarzyna and Klemarczyk, Witold and Strucińska, Małgorzata and Ambroszkiewicz, Jadwiga},
  title = {Differences in Bone Metabolism between Children with Prader–Willi Syndrome during Growth Hormone Treatment and Healthy Subjects: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9159},
  doi = {10.3390/ijms25179159}
}
Kostenlos starten →